Skip to content

AARD AARD Total Operating Expenses

Total Operating Expenses at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$19.46M+6.8%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$164.13M+196%
Arvinas logo
ArvinasARVN
$79.4M-32.4%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$60.02M+26.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$151M+0.7%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's total operating expenses?
AARD (AARD) reported total operating expenses of $22.46M in Q1 2026.
How has AARD's total operating expenses changed year-over-year?
AARD's total operating expenses increased by 114.6% year-over-year, from $10.47M to $22.46M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.